---
category: news
title: "Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma"
excerpt: "PRNewswire/ -- Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR(Â®) artificial intelligence (\"A.I.\") platform to transform cancer drug development and identi"
publishedDateTime: 2020-12-17T12:00:00Z
originalUrl: "https://www.wfmz.com/news/pr_newswire/pr_newswire_business/lantern-pharma-announces-collaboration-with-world-leading-brain-cancer-program-at-johns-hopkins-to-further/article_9bda7c2d-0ed5-568b-9e5e-ddc977facb76.html"
webUrl: "https://www.wfmz.com/news/pr_newswire/pr_newswire_business/lantern-pharma-announces-collaboration-with-world-leading-brain-cancer-program-at-johns-hopkins-to-further/article_9bda7c2d-0ed5-568b-9e5e-ddc977facb76.html"
type: article
quality: 15
heat: 15
published: false

provider:
  name: WFMZ-TV
  domain: wfmz.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://bloximages.newyork1.vip.townnews.com/wfmz.com/content/tncms/assets/v3/editorial/2/90/290d9a51-9a5a-50e0-b093-3f61b545ed96/5fdb4f8c866a5.image.jpg?resize=400%2C296"
    width: 400
    height: 296
    isCached: true

secured: "luoEvZcVk8Aea6L3kZwTBpQNLAR4wRRE9j4rvdGTCvgGJDWI0JewaG0miomNSaBgzqDL8klqTHRh1UrKyb0J3rtX7UNRdhjBlfs9eesRitNp+4ebZtXiNNeXcMLLPGZwLZwkt0zvAj4vn5csIbZVLz3z00gu9IN3yELh4GnVeqn0AGyMbPpi7cGXzg2owIpHIPWvuuyrTUeE4QGXTZcUnhJg9U4RAf9gocE8gCLugdrKy874rhuxwaxc7Mblutw915GgIMYm7qIf87rrobLWZpbxlPjVstG7iHPPEjeRasvjo6ZKuLXe+WquXiUqeduTXNMfphj9kmxXybxwqfE7FCNQr8UxQtN4FoopVLX7VjA=;oYoexAn21i+j2OuPoexnNg=="
---

